LFM
UTHR icon

LGT Fund Management’s United Therapeutics UTHR Stock Holding History

LGT Fund Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,650
Closed -$2.05M – 263
2025
Q1 		$2.05M Hold
6,650
– – 0.18% 120
2024
Q4 		$2.35M Buy
+6,650
New +$2.44M 0.21% 119

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

LGT Fund Management's UTHR Position: Q2 2025 in Review

LGT Fund Management sold out of United Therapeutics (UTHR) in Q2 2025, closing a stake of 6,650 shares — an estimated $2.05M sold.

LGT Fund Management first reported a position in UTHR in Q4 2024 and held it in 2 quarters. The position peaked at $2.35M in Q4 2024. 670 funds tracked by Wall St. Rank hold UTHR as of Q2 2025.

  • LGT Fund Management reported no remaining United Therapeutics position as of Q2 2025 after selling out during the quarter.
  • LGT Fund Management sold 6,650 United Therapeutics shares in Q2 2025, an estimated $2.05M.
  • LGT Fund Management first reported a position in United Therapeutics in Q4 2024 and held it in 2 quarters.
  • LGT Fund Management's United Therapeutics position peaked at $2.35M in Q4 2024.
  • 670 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2025.

Based on LGT Fund Management's 13F filing for Q2 2025, filed 22 Jul 2025.